Detalhe da pesquisa
1.
Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases.
Histopathology
; 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38785043
2.
Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network.
J Eur Acad Dermatol Venereol
; 2024 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38864258
3.
Recurrent FOXK1::GRHL and GPS2::GRHL fusions in trichogerminoma.
J Pathol
; 257(1): 96-108, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35049062
4.
Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational study.
Int J Cancer
; 148(11): 2789-2798, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33428772
5.
Genomic profiling of a skin adnexal carcinomas cohort using a comprehensive high throughput sequencing approach.
Br J Dermatol
; 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38836587
6.
MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 19(7): 916-929, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29908991
7.
Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma.
N Engl J Med
; 371(20): 1877-88, 2014 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25265492
8.
Vismodegib efficacy in unresectable trichoblastic carcinoma: A multicenter study of 16 cases.
J Am Acad Dermatol
; 86(6): 1365-1366, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34052337
9.
Pattern and Severity of Psoriasiform Eruptions in Patients with Inflammatory Bowel Diseases, Arthritis or Skin Inflammatory Disorders Treated with TNF-alpha Inhibitors.
Acta Derm Venereol
; 97(6): 731-734, 2017 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28218339
10.
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial.
Lancet
; 386(9992): 444-51, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26037941
11.
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial.
Lancet Oncol
; 16(6): 729-36, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25981813
12.
Sentinel node status and immunosuppression: recurrence factors in localized Merkel cell carcinoma.
Acta Derm Venereol
; 95(7): 835-40, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25784178
13.
Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study.
Lancet Oncol
; 15(3): 323-32, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24508103
14.
Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
N Engl J Med
; 364(26): 2507-16, 2011 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21639808
15.
Radiation-induced Bullous Lichen Planus: An Isomorphic Manifestation of Radiotherapy.
Acta Derm Venereol
; 99(11): 1033-1034, 2019 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31289839
16.
Ipilimumab in melanoma patients with brain metastasis: a retro-spective multicentre evaluation of thirty-eight patients.
Acta Derm Venereol
; 94(1): 45-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23824275
17.
Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.
J Med Genet
; 50(4): 264-70, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23384855
18.
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial.
Lancet
; 380(9839): 358-65, 2012 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-22735384
19.
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo.
N Engl J Med
; 362(18): 1686-97, 2010 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-20410501
20.
Severity of Local Skin Reactions with 4% 5-Fluorouracil Plus Emollient versus 4% 5-Fluorouracil Alone in Patients with Actinic Keratosis: A Single-Blind Randomised Trial.
Dermatol Ther (Heidelb)
; 13(4): 1013-1027, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36856965